RelA and RelB belong to the nuclear factor-kappa B (NF-kappa B-Rel) transcription factor family. Both proteins are structurally and functionally related, but their intracellular and tissue distributions are different. In resting cells, RelB is found mostly in the nucleus, whereas RelA is sequestered in the cytosol by protein inhibitors, among which I kappa B alpha is the dominant form in lymphocytes. Upon cellular activation I kappa B alpha is proteolyzed, allowing RelA dimers to enter the nucleus and activate target genes. To study the selectivity of gene regulation by RelA and RelB, we generated T cell lines stably expressing a dominant negative mutant of I kappa B alpha. We show that selective inhibition of RelA-NF-kappa B decreased induction of NPKB1, interleukin-2, and interleukin-2R alpha genes but not c-myc. Transcription driven by the I kappa B alpha promoter was blocked by the transgenic I kappa B alpha; however, wild type I kappa B alpha was expressed in the transgenic cell clones but with much slower kinetics than that in control cells. Wild type I kappa B alpha expression was concomitant with RelB up-regulation, suggesting that RelB could be involved in transcription of I kappa B alpha through binding to an alternative site. These results indicate that RelB and RelA have both distinct and overlapping effects on gene expression.